Physician profile
Peter H Park
NPI 1750328860
$20,087.77
in general payments reported to CMS, 2019-2025
36 companies · $5,938 in 2025
The $5,938 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,275 · 2020: $351 · 2021: $947 · 2022: $1,738 · 2023: $2,277 · 2024: $7,563 · 2025: $5,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,300 · Food and Beverage: $5,508 · Travel and Lodging: $900 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,300.00 |
| Food and Beverage | $5,508.29 |
| Travel and Lodging | $899.99 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $5,726.28 | 2019-2025 | Carto 3, Qdot Micro, Smartablatetm System Rf Generator |
| Medical Device Business Services, INC. | $4,800.00 | 2024 | Carto 3 |
| Boston Scientific Corporation | $2,692.96 | 2019-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Abbott Laboratories | $2,126.88 | 2020-2025 | Amplatzer Amulet, Tacticath Ablation Catheter, Sensor Enabled, Flexability |
| Atricure, INC. | $605.90 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Impulse Dynamics (USA) INC. | $477.97 | 2021-2023 | Optimizer |
| Medtronic, INC. | $410.65 | 2021-2025 | Micra, Selectsecure, Linq II |
| Janssen Pharmaceuticals, INC | $385.87 | 2020-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $371.52 | 2020-2025 | Lifevest |
| Cordis US Corp. | $342.77 | 2025 | Mynx Control Venous |
| Kestra Medical Technology Services, INC. | $276.44 | 2022-2025 | Assure Wcd |
| Irhythm Technologies, INC. | $246.36 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Acutus Medical, INC. | $194.90 | 2022 | |
| Pfizer INC. | $181.84 | 2019-2025 | |
| Amgen INC. | $141.38 | 2019-2025 | Repatha, Repatha |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $134.69 | 2019 | |
| Cvrx, INC. | $125.28 | 2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.65 | 2019-2023 | Jardiance |
| Volta Medical INC | $123.47 | 2024 | Vx1 |
| Sanofi-Aventis U.S. LLC | $111.96 | 2019-2023 | |
| Philips North America LLC | $71.53 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $66.86 | 2020-2023 | Camzyos, Eliquis |
| Stereotaxis INC | $51.44 | 2022 | |
| Novo Nordisk INC | $46.44 | 2024 | Wegovy, Ozempic |
| Vital Connect, INC | $40.09 | 2024-2025 | Vitalpatch Rtm |
| Medtronic Vascular, INC. | $30.77 | 2020 | |
| Recor Medical INC | $29.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Genzyme Corporation | $27.19 | 2024 | |
| Catheter Precision INC. | $24.74 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $17.47 | 2023 | Arcalyst |
| United Therapeutics Corporation | $17.34 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.35 | 2023 | |
| Edwards Lifesciences Corporation | $12.80 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.69 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.08 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.